Trials / Completed
CompletedNCT03121573
Efficacy and Safety of Duloxetine Among Individuals With Depressive Disorder in a 12 Weeks Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Taichung Veterans General Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study was to investigate the effects of duloxetine on improvement of brain cortical activity in patients suffering from major depressive disorder using near infrared spectroscopy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Duloxetine | duloxetine 30 to 60 mg tablets by mouth, QD to BID per day, |
Timeline
- Start date
- 2014-12-15
- Primary completion
- 2016-09-26
- Completion
- 2017-01-17
- First posted
- 2017-04-20
- Last updated
- 2017-04-20
Source: ClinicalTrials.gov record NCT03121573. Inclusion in this directory is not an endorsement.